Objective: To analyze surgical outcomes and tumor characteristics of 49 patients with thyrotropin-secreting pituitary adenoma, a rare functional pituitary adenoma subtype with challenging surgery, who underwent endoscopic endonasal transsphenoidal surgery.

Methods: In this single-center study, clinical, radiological, surgical, and endocrinological data of 49 patients diagnosed with thyrotropin-secreting pituitary adenoma were retrospectively reviewed.

Results: Mean tumor size was 21.12 mm (6 microadenomas, 41 macroadenomas, 2 giant adenomas). Cavernous sinus invasion was present in 12 (24.48%) patients. Tumor consistency was firm in 23 (46.93%) patients. Plurihormonal secretion characteristics were present in 9 patients (5 growth hormone + thyrotropin and 4 growth hormone + prolactin + thyrotropin). Mean follow-up duration was 51.73 months. Of the cases with firm tumors, 14 patients had a history of antithyroid drug use; there was no statistically significant correlation between the antithyroid medication and the firmness of the tumor. Gross total resection was achieved in 32 (65.30%) cases, near-total resection was achieved in 14 (28.57%) cases, and subtotal resection was achieved in 3 (6.12%) cases. The analysis showed that the negative effect of >2 cm tumor size and cavernous sinus invasion on resection rate was statistically significant (P < 0.001). Although early remission was achieved in 33 (67.34%) patients, 44 (89.79%) patients were in euthyroid state at >3 months' follow-up. Complications were 4 new-onset pituitary deficiencies, 3 cases of permanent diabetes insipidus, 1 thyrotoxic crisis, and 1 cerebrospinal fluid leak.

Conclusions: Endoscopic endonasal transsphenoidal surgery is the first-line treatment in thyrotropin-secreting pituitary adenoma and should be performed in a tertiary center. Gross total resection is the goal, and early diagnosis is essential for surgical success.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2022.09.027DOI Listing

Publication Analysis

Top Keywords

thyrotropin-secreting pituitary
16
pituitary adenoma
16
endoscopic endonasal
12
endonasal transsphenoidal
12
resection achieved
12
patients
9
characteristics patients
8
tumor size
8
cavernous sinus
8
sinus invasion
8

Similar Publications

Article Synopsis
  • Thyrotropin-secreting pituitary neuroendocrine tumors (PitNETs) are rare, with mixed TSH PitNETs accounting for 20-25% of cases; this study focuses on a unique case of mixed TSH PitNET in a patient with Graves' disease (GD).
  • The 36-year-old male exhibited symptoms of hyperthyroidism, high hormone levels, and positive thyroid antibodies, but no signs of acromegaly; he underwent surgical resection of the tumor which was identified as a mixed pituitary adenoma.
  • Post-surgery, the patient experienced a recurrence of hyperthyroidism and TSH PitNET confirmed by PET-CT, leading to treatment with lanreotide,
View Article and Find Full Text PDF

Early identification of postoperative remission for thyrotropin-secreting adenomas.

Clin Endocrinol (Oxf)

September 2024

Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai, China.

Objective: Thyrotropin-secreting adenoma (TSHoma) is a rare type of pituitary adenoma, occurring in one per million people. Little is known about TSHoma. We summarized the demographic, clinical and hormonal characteristics of TSHoma based on a single-centre experience.

View Article and Find Full Text PDF

Background: Thyrotropin-secreting pituitary adenomas (TSH-PA) are a rare cause of thyrotoxicosis and account for 0.5-2% of all pituitary adenomas. Taking into account the rarity of the disease, it is extremely important to analyze each case of TSH-PA.

View Article and Find Full Text PDF

Backgruound: Thyroid-stimulating hormone (TSH)-secreting pituitary neuroendocrine tumor (TSH PitNET) is a rare subtype of PitNET. We investigated the comprehensive characteristics and outcomes of TSH PitNET cases from a single medical center. Also, we compared diagnostic methods to determine which showed superior sensitivity.

View Article and Find Full Text PDF

Gamma knife radiosurgery is effective in patients with thyrotropin-secreting pituitary adenomas.

J Endocrinol Invest

August 2024

Neurosurgery and Radiosurgery Unit, IRCCS San Raffaele Scientific Institute, Vita-Salute University San Raffaele, Via Olgettina 60, 20132, Milan, Italy.

Purpose: Thyrotropin (TSH)-secreting pituitary adenoma (TSHoma) is a rare cause of TSH-dependent hyperthyroidism. The first therapeutic option is surgery. Medical treatment with somatostatin analogs is also effective.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!